Stormorken-sjaastad-langslet Syndrome

Description

Stormorken-Sjaastad-Langslet syndrome is characterized by thrombocytopathy, asplenia, miosis, muscle fatigue, migraine, dyslexia, and ichthyosis. It has been described in six members of one family. It is transmitted as an autosomal dominant trait.

Clinical Features

Top most frequent phenotypes and symptoms related to Stormorken-sjaastad-langslet Syndrome

  • Short stature
  • Muscle weakness
  • Anemia
  • Fatigue
  • Myopathy
  • Headache
  • Dilatation
  • Thrombocytopenia
  • Elevated serum creatine phosphokinase
  • Severe short stature

And another 31 symptoms. If you need more information about this disease we can help you.

Click here to know more about Mendelian.

Incidence and onset information

— Currently we don't have prevalence information about this disease (Not enough data available about incidence and published cases.)
No data available about the known clinical features onset.

Alternative names

Stormorken-sjaastad-langslet Syndrome Is also known as thrombocytopathy-asplenia-miosis syndrome, york platelet syndrome, thrombocytopathy, asplenia, and miosis, yps, stormorken syndrome.

Researches and researchers

Currently, we don't have any information about doctors, researches or researchers related to this disease. Please contact us if you would like to appear here.


Mendelian

Accelerate your rare disease diagnosis with us

Learn more

Stormorken-sjaastad-langslet Syndrome Recommended genes panels

Panel Name, Specifity and genes Tested/covered
Severe Combined Immunodeficiency and T Cell Disorders Panel by next-generation sequencing (NGS).

By Cincinnati Children's Hospital Medical Center Laboratory of Genetics and Genomics Cincinnati Children's Hospital Medical Center (United States).

RMRP, STAT5B, STIM1, TBX1, FOXN1, ZAP70, CD3D, CD3E, DCLRE1C, ADA, NHEJ1, ORAI1, IL2RG, IL7R, JAK3, LIG4, PNP, PTPRC, RAG1, RAG2
Specificity
10 %
Genes
100 %
ORAI1 Sequencing.

By Cincinnati Children's Hospital Medical Center Laboratory of Genetics and Genomics Cincinnati Children's Hospital Medical Center (United States).

ORAI1
Specificity
100 %
Genes
50 %
Severe Combined Immunodeficiency and T Cell Disorders Deletion/Duplication Panel.

By Cincinnati Children's Hospital Medical Center Laboratory of Genetics and Genomics Cincinnati Children's Hospital Medical Center (United States).

RMRP, STAT5B, STIM1, TBX1, FOXN1, ZAP70, CD3D, CD3E, ADA, NHEJ1, ORAI1, IL2RG, IL7R, JAK3, LIG4, PNP, PTPRC, RAG1, RAG2
Specificity
11 %
Genes
100 %
ORAI1 Deletion/duplication analysis.

By Cincinnati Children's Hospital Medical Center Laboratory of Genetics and Genomics Cincinnati Children's Hospital Medical Center (United States).

ORAI1
Specificity
100 %
Genes
50 %
Neuromuscular Disorders Sequencing Panel.

By Genetic Services Laboratory University of Chicago (United States).

RYR1, BIN1, SCN4A, SGCA, SGCB, SGCD, SGCG, SNAP25, STIM1, SYT2, TCAP, TNNT1, TNXB, TPM2, TPM3, MYOT, TTN, VCP, ACTA1, RXYLT1 , (...)

View the complete list with 91 more genes
Specificity
2 %
Genes
100 %
Myopathy with Tubular Aggregates Sequencing Panel.

By Genetic Services Laboratory University of Chicago (United States).

STIM1, ORAI1
Specificity
100 %
Genes
100 %
ORAI1.

By Institute for Human Genetics University Clinic Freiburg (Germany).

ORAI1
Specificity
100 %
Genes
50 %
Muscle Weakness (Myopathy, Muscular Dystrophy).

By MGZ Medical Genetics Center (Germany).

RYR1, BIN1, SCN4A, SCO2, SDHA, SGCA, SGCB, SGCD, SGCG, SLC22A5, SLC25A3, SLC25A4, SLC6A5, SNAP25, STIM1, TAZ, TWNK, TCAP, TIA1, TK2 , (...)

View the complete list with 159 more genes
Specificity
2 %
Genes
100 %

We have 38 more panels available in our App

Get the app

Sources and references

You can check the following sources for additional information.

MESH OMIM ORPHANET Rare Disease Symptoms Checker

If you liked this article maybe you will also find interesting the following in-depth articles about other rare diseases, like PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 4; PEOA4 STICKLER SYNDROME, TYPE II; STL2 GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 7; GEFSP7 EPILEPSY, FAMILIAL TEMPORAL LOBE, 7; ETL7 MITOCHONDRIAL DNA DEPLETION SYNDROME 13 (ENCEPHALOMYOPATHIC TYPE); MTDPS13

Need help with a diagnosis?

Learn more about how to achieve it with Mendelian


Learn more